We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
-6.08%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$258M
AUM Growth
+$1.75M
Cap. Flow
+$19.8M
Cap. Flow %
7.67%
Top 10 Hldgs %
13.01%
Holding
216
New
68
Increased
46
Reduced
72
Closed
30

Sector Composition

Rank Sector Weight
1 Financials 20.33%
2 Industrials 15.18%
3 Real Estate 14.54%
4 Technology 9.42%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWD
151
DELISTED
American Woodmark
AMWD
$307K 0.12%
+8,320
New +$287K
SYKE
152
DELISTED
SYKES Enterprises Inc
SYKE
$307K 0.12%
+15,380
New +$320K
OWW
153
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$307K 0.12%
+39,060
New +$335K
AEIS icon
154
Advanced Energy
AEIS
$13B
$306K 0.12%
+16,300
New +$300K
AIMC
155
DELISTED
Altra Industrial Motion Corp
AIMC
$306K 0.12%
10,510
+4,690
+81% +$157K
MMS icon
156
Maximus
MMS
$3.11B
$304K 0.12%
+7,570
New +$313K
SIMG
157
DELISTED
SILICON IMAGE INC
SIMG
$304K 0.12%
60,340
+26,910
+80% +$134K
FINL
158
DELISTED
Finish Line
FINL
$303K 0.12%
12,120
+5,410
+81% +$155K
SGI
159
Somnigroup International
SGI
$13.7B
$302K 0.12%
+21,520
New +$315K
IRWD icon
160
Ironwood Pharmaceuticals
IRWD
$711M
$300K 0.12%
+27,665
New +$317K
TBI
161
Trueblue
TBI
$311M
$299K 0.12%
+11,830
New +$328K
PRAA icon
162
PRA Group
PRAA
$755M
$298K 0.12%
+5,700
New +$328K
NXGN
163
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$297K 0.12%
21,600
+11,550
+115% +$175K
CVLT icon
164
Commault Systems
CVLT
$5.61B
$295K 0.11%
+5,850
New +$301K
ATML
165
DELISTED
ATMEL CORP
ATML
$294K 0.11%
+36,400
New +$315K
MSTR icon
166
Strategy Inc
MSTR
$38.4B
$291K 0.11%
+22,270
New +$310K
CYNO
167
DELISTED
Cynosure, Inc. Class A
CYNO
$291K 0.11%
+13,880
New +$305K
ARIA
168
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$291K 0.11%
+53,980
New +$315K
BWLD
169
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$289K 0.11%
+2,149
New +$318K
AFFX
170
DELISTED
Affymetrix Inc
AFFX
$287K 0.11%
+36,020
New +$309K
MDCO
171
DELISTED
Medicines Co
MDCO
$284K 0.11%
12,720
+5,680
+81% +$144K
ARAY icon
172
Accuray
ARAY
$34M
$280K 0.11%
+38,520
New +$312K
SBGI icon
173
Sinclair Inc
SBGI
$1.03B
$279K 0.11%
+10,690
New +$328K
RTEC
174
DELISTED
Rudolph Technologies Inc
RTEC
$278K 0.11%
30,709
+13,690
+80% +$131K
FLO icon
175
Flowers Foods
FLO
$1.57B
$276K 0.11%
+15,030
New +$293K

Similar funds

Piermont Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Piermont Capital Management held 216 positions worth $258M, up 0.68% from $256M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Piermont Capital Management deployed $19.8M of net new capital in Q3 2014, opening 68 new positions and adding to 46 existing holdings. Its largest new stake was Vitamin Shoppe Inc.: 73,240 shares worth $3.25M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Real Estate.

On the sell side, the largest reduction was Minerals Technologies, an estimated $2.95M trimmed.

  • Piermont Capital Management's largest Q3 2014 buy was Vitamin Shoppe Inc.: 73,240 shares worth $3.25M.
  • Piermont Capital Management added most to Materion in Q3 2014, an estimated $2.82M increase.
  • Piermont Capital Management's biggest Q3 2014 reduction was Minerals Technologies, cutting an estimated $2.95M.
  • Piermont Capital Management fully exited OMNIVISION TECHNOLOGIES INC in Q3 2014, selling an estimated $2.96M.
  • Piermont Capital Management's ten largest holdings make up 13% of its $258M portfolio in Q3 2014.
  • Piermont Capital Management opened 68 new positions and closed 30 in Q3 2014.
  • Piermont Capital Management's portfolio value rose 0.68% quarter-over-quarter to $258M.

Based on Piermont Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.